Tommaso Claudio Mineo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tommaso Claudio Mineo has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Vincenzo Ambrogi
21 shared publicationsEugenio Pompeo
12 shared publicationsDavide Mineo
Thoracic Surgery Division, Policlinico Tor Vergata University, Rome, Italy
4 shared publications- Alfonso Baldi
Department of Life Health Sciences and Health Professions, Link Campus University, Rome, Italy
3 shared publications - Giuseppe Tonini
Università Campus Bio-Medico di Roma
3 shared publications Italo Nofroni
3 shared publications
Latest Publications
- 1 September 2018
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 4, 189
Thymectomy for thymoma spanning three decades at Tor Vergata thoracic surgery center
Background: Thymoma is most common primary neoplasm of the anterior mediastinum in the adult population. Surgery remains the cornerstone of the treatment. Methods: In a three decades period [1986–2015] we performed a total of 225 patients for thymoma through open (n=182) or minimally invasive access (n=43) achieving 189 complete resections. Data were reviewed and main prognostic factors considered by Kaplan-Meier and log rank methods. Results: Completeness of resection, Masaoka stage, WHO histology, cell cycle protein expression and preoperative neutrophil to lymphocytes ratio were significant prognosticators. Whereas concomitant myasthenia gravis (MG) and surgical approach were not. Recurrences are slow-growing and deserves always aggressive treatment. Conclusions: Despite the bias due to the long time-span, our analysis allows the evaluation of the whole aspects of this surgery and results are in accordance with those already reported in the literature. New prognostic factors such as cell cycle proteins expression and preoperative neutrophil to lymphocytes ratio resulted significant.
- 1 September 2018
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 4, 189
Thymectomy for thymoma spanning three decades at Tor Vergata thoracic surgery center
Background: Thymoma is most common primary neoplasm of the anterior mediastinum in the adult population. Surgery remains the cornerstone of the treatment. Methods: In a three decades period [1986–2015] we performed a total of 225 patients for thymoma through open (n=182) or minimally invasive access (n=43) achieving 189 complete resections. Data were reviewed and main prognostic factors considered by Kaplan-Meier and log rank methods. Results: Completeness of resection, Masaoka stage, WHO histology, cell cycle protein expression and preoperative neutrophil to lymphocytes ratio were significant prognosticators. Whereas concomitant myasthenia gravis (MG) and surgical approach were not. Recurrences are slow-growing and deserves always aggressive treatment. Conclusions: Despite the bias due to the long time-span, our analysis allows the evaluation of the whole aspects of this surgery and results are in accordance with those already reported in the literature. New prognostic factors such as cell cycle proteins expression and preoperative neutrophil to lymphocytes ratio resulted significant.
- 1 July 2018
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 4 (7) , 154
Surgery moves forward
- 1 July 2018
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 4 (7) , 154
Surgery moves forward
- Open Access
- 1 March 2018
- Published by European Medical Group in European Medical Journal
- Vol. 3 (1) , 68-75
Early and Long-Term Outcomes After Non-Intubated, Non-Resectional Lung Volume Reduction Surgery
In 2001, the introduction of non-resectional lung volume reduction surgery (LVRS) enabled surgery under non-intubated anaesthesia. This study compares...
- 1 March 2018
- Published by European Medical Group in European Medical Journal
- Vol. 3 (1) , 68-75
Open AccessEarly and Long-Term Outcomes After Non-Intubated, Non-Resectional Lung Volume Reduction Surgery
In 2001, the introduction of non-resectional lung volume reduction surgery (LVRS) enabled surgery under non-intubated anaesthesia. This study compares...
- 1 February 2018
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 3 (2) , 5
Innovation in awake VATS
- 1 February 2018
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 3 (2) , 5
Innovation in awake VATS
- 17 January 2018
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 3 (1) , 4
Immune effects after uniportal nonintubated video-thoracoscopic operations
Background: We hypothesized that uniportal video-assisted thoracic surgery (VATS) under nonintubated anesthesia may have a lesser immunological impact than same procedures under general anesthesia. Methods: Between December 2005 and October 2016, a total of consecutive 878 patients underwent VATS operations under nonintubated anesthesia. In a subset of 542 patients we assessed lymphocyte subpopulations at 1, 7 and 14 days postoperatively and matched with a control group of 106 patients who underwent uniportal intubated surgery. Results: Global time spent in the operative room was significantly longer in intubated group (85±41 vs. 118±34 minutes; P=0.03). The total lymphocytes count showed a lesser drop in the nonintubated group at post-operative day 7 (P=0.04) and 14 (P=0.05) with a significant lesser reduction of natural killer lymphocytes at day 7 (P=0.03) and 14 (P=0.04). 30-day mortality (0.9% vs. 4.7%; P=0.04), major morbidity (9.5% vs. 19%; P=0.03) and hospital stay (4.2±2.8 vs. 6.1±2.6 days; P=0.04) were significantly lower in the nonintubated group. Survival rate in the subset of patients operated for malignant effusion was significantly higher in the nonintubated group (P=0.03). Conclusions: Uniportal nonintubated operations demonstrated a significant lower impact on immunological response compared to the traditional procedure in general anesthesia. This impacted postoperative 30-day mortality, major morbidity and hospital stay. We also found a significant influence on long-term survival in a consistent subset of patients operated for malignant pleural effusion.
- 17 January 2018
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 3 (1) , 4
Immune effects after uniportal nonintubated video-thoracoscopic operations
Background: We hypothesized that uniportal video-assisted thoracic surgery (VATS) under nonintubated anesthesia may have a lesser immunological impact than same procedures under general anesthesia. Methods: Between December 2005 and October 2016, a total of consecutive 878 patients underwent VATS operations under nonintubated anesthesia. In a subset of 542 patients we assessed lymphocyte subpopulations at 1, 7 and 14 days postoperatively and matched with a control group of 106 patients who underwent uniportal intubated surgery. Results: Global time spent in the operative room was significantly longer in intubated group (85±41 vs. 118±34 minutes; P=0.03). The total lymphocytes count showed a lesser drop in the nonintubated group at post-operative day 7 (P=0.04) and 14 (P=0.05) with a significant lesser reduction of natural killer lymphocytes at day 7 (P=0.03) and 14 (P=0.04). 30-day mortality (0.9% vs. 4.7%; P=0.04), major morbidity (9.5% vs. 19%; P=0.03) and hospital stay (4.2±2.8 vs. 6.1±2.6 days; P=0.04) were significantly lower in the nonintubated group. Survival rate in the subset of patients operated for malignant effusion was significantly higher in the nonintubated group (P=0.03). Conclusions: Uniportal nonintubated operations demonstrated a significant lower impact on immunological response compared to the traditional procedure in general anesthesia. This impacted postoperative 30-day mortality, major morbidity and hospital stay. We also found a significant influence on long-term survival in a consistent subset of patients operated for malignant pleural effusion.
- 1 January 2018
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 30 (2) , 222-227
Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas
- 1 January 2018
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 30 (2) , 222-227
Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas
- 26 September 2017
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 2 (9) , 68
Nonintubated uniportal nonresectional videothoracoscopic lung volume reduction surgery
In 2000, we developed a nonintubated lung volume reduction surgery (LVRS) technique accomplished through a multiport videothoracoscopy. More recently, we performed the same operation through a single-port approach. Hereby, we analyzed comparative merits in short and long-term periods of these two techniques. Between January 2001 and October 2015, 108 patients with severe emphysema underwent multi-portal (n=77) and uniportal (n=31) video-thoracoscopic nonresectional LVRS under nonintubated anesthesia. Respiratory and functional parameters were timely evaluated. Time to residual volume recurrence and overall survival were analyzed with the Kaplan-Meier method. Conversion rate to general anesthesia (multi vs. uniportal) was similar between groups (14.5% vs. 12.1%), whereas postoperative pain (1.8 vs. 1.3; P=0.04) and quality of life changes (+9.2% vs. +16.7%; P=0.03) after 7 days from the operation were significantly lower in uniportal group. Hospital stay (6.8 vs. 5.2 days), 90-days postoperative mortality rate (1.5% vs. 0%) and non-fatal complications rate (15.6% vs. 11.1%) were lower in uniportal group but not significant. All respiratory and symptomatic parameters significantly improved in both groups with no intergroup significant difference. Analysis of time to residual volume recurrence and overall survival showed no statistical significant difference between groups. Nonintubated, uniportal, nonresectional videothoracoscopic LVRS achieves excellent short results with less postoperative pain and better early quality of life than multi-portal operations. Uniportal group exhibited lower 90-day postoperative mortality and non-fatal complication rates even though not significantly different. Long-term outcomes were similar between groups. However, the lesser pain and discomfort of nonintubated uniportal LVRS allows easier recruitment of elderly and high-risk patients as well.
- 26 September 2017
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 2 (9) , 68
Nonintubated uniportal nonresectional videothoracoscopic lung volume reduction surgery
In 2000, we developed a nonintubated lung volume reduction surgery (LVRS) technique accomplished through a multiport videothoracoscopy. More recently, we performed the same operation through a single-port approach. Hereby, we analyzed comparative merits in short and long-term periods of these two techniques. Between January 2001 and October 2015, 108 patients with severe emphysema underwent multi-portal (n=77) and uniportal (n=31) video-thoracoscopic nonresectional LVRS under nonintubated anesthesia. Respiratory and functional parameters were timely evaluated. Time to residual volume recurrence and overall survival were analyzed with the Kaplan-Meier method. Conversion rate to general anesthesia (multi vs. uniportal) was similar between groups (14.5% vs. 12.1%), whereas postoperative pain (1.8 vs. 1.3; P=0.04) and quality of life changes (+9.2% vs. +16.7%; P=0.03) after 7 days from the operation were significantly lower in uniportal group. Hospital stay (6.8 vs. 5.2 days), 90-days postoperative mortality rate (1.5% vs. 0%) and non-fatal complications rate (15.6% vs. 11.1%) were lower in uniportal group but not significant. All respiratory and symptomatic parameters significantly improved in both groups with no intergroup significant difference. Analysis of time to residual volume recurrence and overall survival showed no statistical significant difference between groups. Nonintubated, uniportal, nonresectional videothoracoscopic LVRS achieves excellent short results with less postoperative pain and better early quality of life than multi-portal operations. Uniportal group exhibited lower 90-day postoperative mortality and non-fatal complication rates even though not significantly different. Long-term outcomes were similar between groups. However, the lesser pain and discomfort of nonintubated uniportal LVRS allows easier recruitment of elderly and high-risk patients as well.
- Open Access
- 7 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (7) , 1466
Immunological and Inflammatory Impact of Non-Intubated Lung Metastasectomy
Background: We hypothesized that video-assisted thoracic surgery (VATS) lung metastasectomy under non-intubated anesthesia may have a lesser immunological and inflammatory impact than the same procedure under general anesthesia. Methods: Between December 2005 and October 2015, 55 patients with pulmonary oligometastases (at the first episode) successfully underwent VATS metastasectomy under non-intubated anesthesia. Lymphocytes subpopulation and interleukins 6 and 10 were measured at different intervals and matched with a control group composed of 13 patients with similar clinical features who refused non-intubated surgery. Results: The non-intubated group demonstrated a lesser reduction of natural killer lymphocytes at 7 days from the procedure (p = 0.04) compared to control. Furthermore, the group revealed a lesser spillage of interleukin 6 after 1 (p = 0.03), 7 (p = 0.04), and 14 (p = 0.05) days. There was no mortality in any groups. Major morbidity rate was significantly higher in the general anesthesia group 3 (5%) vs. 3 (23%) (p = 0.04). The median hospital stay was 3.0 vs. 3.7 (p = 0.033) days, the estimated costs with the non-intubated procedure was significantly lower, even excluding the hospital stay. Conclusions: VATS lung metastasectomy in non-intubated anesthesia had significantly lesser impact on both immunological and inflammatory response compared to traditional procedure in intubated general anesthesia.
- 7 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (7) , 1466
Open AccessImmunological and Inflammatory Impact of Non-Intubated Lung Metastasectomy
Background: We hypothesized that video-assisted thoracic surgery (VATS) lung metastasectomy under non-intubated anesthesia may have a lesser immunological and inflammatory impact than the same procedure under general anesthesia. Methods: Between December 2005 and October 2015, 55 patients with pulmonary oligometastases (at the first episode) successfully underwent VATS metastasectomy under non-intubated anesthesia. Lymphocytes subpopulation and interleukins 6 and 10 were measured at different intervals and matched with a control group composed of 13 patients with similar clinical features who refused non-intubated surgery. Results: The non-intubated group demonstrated a lesser reduction of natural killer lymphocytes at 7 days from the procedure (p = 0.04) compared to control. Furthermore, the group revealed a lesser spillage of interleukin 6 after 1 (p = 0.03), 7 (p = 0.04), and 14 (p = 0.05) days. There was no mortality in any groups. Major morbidity rate was significantly higher in the general anesthesia group 3 (5%) vs. 3 (23%) (p = 0.04). The median hospital stay was 3.0 vs. 3.7 (p = 0.033) days, the estimated costs with the non-intubated procedure was significantly lower, even excluding the hospital stay. Conclusions: VATS lung metastasectomy in non-intubated anesthesia had significantly lesser impact on both immunological and inflammatory response compared to traditional procedure in intubated general anesthesia.
- 3 June 2017
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 2 (6) , 32
Left-sided video-assisted thoracic surgery thymectomy
Thymectomy is widely used as integrated treatment of patients with non-thymomatous myasthenia gravis (MG) and in the case of early thymomas. However, the best approach to thymus is still under debate. For decades, median sternotomy was the only option offered. This access provides a massive exposure of the anterior mediastinum allowing an extended thymectomy with the exenteration of the whole mediastinal fat, which are the two mainstays for the therapeutic success of the procedure. Unfortunately, median sternotomy produces a quite significant tissue trauma, with a certain morbidity rate and relevant postoperative pain, thus leading to longer hospital stay. Furthermore, it implies the creation of an unpleasant scar thus meeting a very low acceptance rate in patient’s population manly represented by young women. Over the years, video-assisted thoracic surgery (VATS) thymectomy has progressively replaced transsternal accesses. This approach proved safe and as extended as an open one. The procedure is better accepted by both patients and neurologists given the less postoperative pain, the insignificant cosmetic side-effects and the faster return to normal living and occupational activities. VATS thymectomy requires a perfect preparation and stabilization of the patient by a multidisciplinary group, perfect patient lying on operatory table, correct positioning of trocars, excellent knowledge of mediastinal anatomy gained through a certain number of previous sternotomies, rehearsed surgical team including an anesthesiologist experienced in myasthenic disease. Surgical steps follow grossly a precise sequence, which entails dissection of lower horns, dissection of the veins and dissection of the upper horns. Major complications are represented by innominate vein injury, which often requires rapid conversion to median sternotomy. The procedure can be feasible from either side of the thorax. Since the beginning we preferred the left-sided approach for a number of reasons such as best visualization of the left pericardio-phrenic angle, innominate vein and aorto-pulmonary window, which are most frequently sites of ectopic thymic tissue. However, each side presents different advantages and limits. Long-term results appear similarly effective in the majority of the available series. The choice of the side is prevalently based on the surgeon’s preference and experience, but one should also consider the prevalent location of the thymus or thymoma, and other local conditions predicted by imaging. In conclusion, whatever the side VATS can provide safe, effective and extended thymectomy.
- 3 June 2017
- Published by AME Publishing Company in Video-Assisted Thoracic Surgery
- Vol. 2 (6) , 32
Left-sided video-assisted thoracic surgery thymectomy
Thymectomy is widely used as integrated treatment of patients with non-thymomatous myasthenia gravis (MG) and in the case of early thymomas. However, the best approach to thymus is still under debate. For decades, median sternotomy was the only option offered. This access provides a massive exposure of the anterior mediastinum allowing an extended thymectomy with the exenteration of the whole mediastinal fat, which are the two mainstays for the therapeutic success of the procedure. Unfortunately, median sternotomy produces a quite significant tissue trauma, with a certain morbidity rate and relevant postoperative pain, thus leading to longer hospital stay. Furthermore, it implies the creation of an unpleasant scar thus meeting a very low acceptance rate in patient’s population manly represented by young women. Over the years, video-assisted thoracic surgery (VATS) thymectomy has progressively replaced transsternal accesses. This approach proved safe and as extended as an open one. The procedure is better accepted by both patients and neurologists given the less postoperative pain, the insignificant cosmetic side-effects and the faster return to normal living and occupational activities. VATS thymectomy requires a perfect preparation and stabilization of the patient by a multidisciplinary group, perfect patient lying on operatory table, correct positioning of trocars, excellent knowledge of mediastinal anatomy gained through a certain number of previous sternotomies, rehearsed surgical team including an anesthesiologist experienced in myasthenic disease. Surgical steps follow grossly a precise sequence, which entails dissection of lower horns, dissection of the veins and dissection of the upper horns. Major complications are represented by innominate vein injury, which often requires rapid conversion to median sternotomy. The procedure can be feasible from either side of the thorax. Since the beginning we preferred the left-sided approach for a number of reasons such as best visualization of the left pericardio-phrenic angle, innominate vein and aorto-pulmonary window, which are most frequently sites of ectopic thymic tissue. However, each side presents different advantages and limits. Long-term results appear similarly effective in the majority of the available series. The choice of the side is prevalently based on the surgeon’s preference and experience, but one should also consider the prevalent location of the thymus or thymoma, and other local conditions predicted by imaging. In conclusion, whatever the side VATS can provide safe, effective and extended thymectomy.
- Open Access
- 29 March 2016
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 152 (1) , 280-281
Moving around the thymus: More technology, more safety, more efficiency
- 29 March 2016
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 152 (1) , 280-281
Open AccessMoving around the thymus: More technology, more safety, more efficiency